2.4.1.47: N-acylsphingosine galactosyltransferase
This is an abbreviated version!
For detailed information about N-acylsphingosine galactosyltransferase, go to the full flat file.
Word Map on EC 2.4.1.47
-
2.4.1.47
-
myelin
-
oligodendrocyte
-
sulfatide
-
udp-galactose:ceramide
-
galactosylceramide
-
galactocerebroside
-
galcer
-
2.4.1.45
-
myelin-specific
-
3'-phosphohydrolase
-
3'-phosphodiesterase
-
myelin-related
-
sulfoglycolipids
-
udp-glucose:ceramide
-
galactosphingolipids
-
paranodal
-
medicine
- 2.4.1.47
- myelin
- oligodendrocyte
- sulfatide
-
udp-galactose:ceramide
- galactosylceramide
- galactocerebroside
-
galcer
-
2.4.1.45
-
myelin-specific
-
3'-phosphohydrolase
- 3'-phosphodiesterase
-
myelin-related
-
sulfoglycolipids
-
udp-glucose:ceramide
-
galactosphingolipids
-
paranodal
- medicine
Reaction
Synonyms
ceramide galactosyltransferase, cerebroside synthase, CGalT, CGT, EC 2.4.1.45, galactosyltransferase, uridine diphosphogalactose-2-hydroxyacylsphingosine, galactosyltransferase, uridine diphosphogalactose-acylsphingosine, GALT, UDP galactose-N-acylsphingosine galactosyltransferase, UDPgalactose-2-hydroxyacylsphingosine galactosyltransferase, UDPgalactose:2-2-hydroxyacylsphingosine galactosyltransferase, UDPgalactose:ceramide galactosyltransferase, UGT8, uridine diphosphogalactose-2-hydroxyacylsphingosine galactosyltransferase, uridine diphosphogalactose-acylsphingosine galactosyltransferase
ECTree
Advanced search results
Application
Application on EC 2.4.1.47 - N-acylsphingosine galactosyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
-
study of CGT expression and polymorphism may provide a clue for the understanding of neuropathological diseases involving myelin and myelination
medicine
study on UGT8 expression in tissue specimens of primary and corresponding metastatic lung tumors in 19 non-small cell lung carcinoma patients undergoing surgery. The majority of both lung primary and metastatic tumor tissues are positive in UGT8 signals. The cytoplasmic expression of UGT8 is found in 68.4% of cases of primary tumors and 82.2% of metastases, with a positive correlation between the UGT8 expression in both tumor tissues. The normal tissue adjacent to tumors shows no positive UGT8 staining. There is no appreciable difference in UGT8 expression depending on the clinical stage of non-small cell lung carcinoma or lymph node involvement found nor is there any association between UGT8 expression in tumor tissues and patients' survival time. UGT8, although enhanced in non-small cell lung carcinoma tissues, does not meet the criteria of a lung tumor marker